First Command Bank’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$3.15K Hold
100
﹤0.01% 379
2023
Q1
$2.72K Hold
100
﹤0.01% 357
2022
Q4
$3K Hold
100
﹤0.01% 360
2022
Q3
$3K Hold
100
﹤0.01% 364
2022
Q2
$3K Hold
100
﹤0.01% 374
2022
Q1
$3K Hold
100
﹤0.01% 371
2021
Q4
$5K Hold
100
﹤0.01% 402
2021
Q3
$5K Hold
100
﹤0.01% 402
2021
Q2
$5K Hold
100
﹤0.01% 391
2021
Q1
$5K Hold
100
﹤0.01% 385
2020
Q4
$5K Buy
+100
New +$4.76K ﹤0.01% 336

Other funds holding SBIO

First Command Bank's SBIO Position: Q2 2023 in Review

First Command Bank held its ALPS Medical Breakthroughs ETF (SBIO) position steady in Q2 2023 at 100 shares worth $3.15K. The position accounts for ﹤0.01% of the portfolio, ranked #379.

First Command Bank first reported a position in SBIO in Q4 2020 and has held it in 11 quarters since. The position peaked at $5K in Q4 2021. 41 funds tracked by Wall St. Rank hold SBIO as of Q2 2023.

  • First Command Bank held 100 shares of ALPS Medical Breakthroughs ETF worth $3.15K as of Q2 2023.
  • First Command Bank left its ALPS Medical Breakthroughs ETF share count unchanged in Q2 2023.
  • ALPS Medical Breakthroughs ETF made up ﹤0.01% of First Command Bank's portfolio in Q2 2023, its #379 holding.
  • First Command Bank first reported a position in ALPS Medical Breakthroughs ETF in Q4 2020 and has held it in 11 quarters since.
  • First Command Bank's ALPS Medical Breakthroughs ETF position peaked at $5K in Q4 2021.
  • 41 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2023.

Based on First Command Bank's 13F filing for Q2 2023, filed 21 Jul 2023.